[1]
P. D. Mạnh, P. K. Toàn, and T. L. Huy, “82. Gefitinib rechallenge After Osimertinib-Induced Interstitial Lung Disease: A Case Report and Literature Review”, TCNCYH, vol. 195, no. 10, pp. 795-800, Oct. 2025.